Other languages bluebird bio, Inc.

Equities

Market Closed - Nasdaq Other stock markets 04:00:00 2024-05-17 pm EDT			5-day change	1st Jan Change
1.03 ^USD	-1.90%		-2.83%	-25.36%

May. 16	Transcript : Bluebird bio, Inc. Presents at Bank of America Health Care Conference 2024, May-16-2024 10:00 AM
May. 09	Transcript : Bluebird bio, Inc., Q1 2024 Earnings Call, May 09, 2024

Bluebird Bio, Inc. Announces Completion of First Cell Collection for LYFGENIA Gene Therapy	May. 06
Bluebird bio Gets Nasdaq Notice for Late Filing of Annual Report	Apr. 26
Bluebird bio to Restate Financial Statements; Shares Fall	Mar. 26
Gene therapy maker bluebird to restate 2022 financials after accounting error	Mar. 26
Sector Update: Health Care Stocks Edge Up Late Monday Afternoon	Mar. 18
Sector Update: Health Care	Mar. 18
Bluebird bio Secures $175 Million Term Loan Facility	Mar. 18
Bluebird bio Signs Medicaid Agreement for Sickle Cell Disease Therapy with Michigan State	Mar. 11
Bluebird bio, Inc. Announces First Outcomes-Based Agreement with Medicaid for Sickle Cell Disease Gene Therapy	Mar. 11
Top Midday Decliners	Dec. 20
Sector Update: Health Care Stocks Mixed Pre-Bell Wednesday	Dec. 20
Top Premarket Decliners	Dec. 20
Bluebird bio Prices $125 Million Stock Offering at $1.50 a Share	Dec. 20
MORNING BRIEFING - Deutschland/Europa	Dec. 20
MÄRKTE USA/Wall Street erklimmt neue Rekordmarken	Dec. 19
MÄRKTE USA/Wall Street mit neuen Rekordmarken	Dec. 19
MÄRKTE USA/Leichte Aufschläge zum Start - Rekordjagd hält an	Dec. 19
MÄRKTE USA/Leichte Aufschläge erwartet	Dec. 19
Bluebird bio Launches $150 Million Share Offering; Shares Slump Premarket	Dec. 19
MARKT USA/Leichte Aufschläge erwartet	Dec. 19

No results for this search